Loxam Teri (CIK 1829111) reported 16 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-16). Recent activity: Buy PCVX (2,265 shares), Buy CMPS (75,000 shares), Sell CMPS (1,781 shares), Sell CMPS (4,467 shares), Buy PCVX (3,041 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | Vaxcyte, Inc. (PCVX) | Director | Buy | 2,265 | $0 |
| 2026-03-27 | COMPASS Pathways plc (CMPS) | Chief Financial Officer | Buy | 75,000 | $0 |
| 2026-03-13 | COMPASS Pathways plc (CMPS) | Chief Financial Officer | Sell | 1,781 | $12,271 |
| 2026-03-03 | COMPASS Pathways plc (CMPS) | Chief Financial Officer | Sell | 4,467 | $31,358 |
| 2025-06-16 | Vaxcyte, Inc. (PCVX) | Director | Buy | 3,041 | $0 |
| 2025-03-13 | COMPASS Pathways plc (CMPS) | Chief Financial Officer | Buy | 25,000 | $0 |
| 2025-03-04 | COMPASS Pathways plc (CMPS) | Chief Financial Officer | Sell | 4,468 | $16,398 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Buy | 6,250 | $141,875 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Sell | 146 | $11,747 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Sell | 215 | $17,529 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Sell | 1,136 | $94,163 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Sell | 1,202 | $100,884 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Sell | 1,043 | $88,957 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Sell | 966 | $83,327 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Sell | 1,013 | $88,516 |
| 2025-01-17 | Vaxcyte, Inc. (PCVX) | Director | Sell | 529 | $46,838 |
Source: SEC Form 4 filings · as of 2026-06-16